| 2.90 Delayed Data As of 3:59pm ET |  +0.08 / +2.84%Today’s Change | 2.49 Today|||52-Week Range 9.95 | -64.06% Year-to-Date |
| Previous close | 2.82 |
| Today’s open | 2.84 |
| Day’s range | 2.80 - 3.01 |
| Volume | 2,322,945 |
| Average volume (3 months) | 2,159,664 |
| Market cap | $342.4M |
| Earnings growth (last year) | -25.81% |
| Earnings growth (this year) | -27.17% |
| Earnings growth (next 5 years) | +19.86% |
| Revenue growth (last year) | -18.00% |
| P/E ratio | NM |
| Price/Sales | 40.32 |
| Price/Book | 6.93 |
| Today’s change | Today’s % change | |
|---|---|---|
| SRNESorrento Therapeutic... | -0.08 | -3.39% |
| ADMAADMA Biologics Inc | -0.04 | -0.76% |
| PFNXPfenex Inc | -0.14 | -1.44% |
| CBMGCellular Biomedicine... | -0.08 | -0.53% |
| Next reporting date | November 6, 2019 |
| EPS forecast (this quarter) | -$0.32 |
| Annual revenue (last year) | $20.7M |
| Annual profit (last year) | -$101.3M |
| Net profit margin | -490.25% |
Sector Health Technology |
Industry Biotechnology |
President, Chief Executive Officer & Director Jon P. Stonehouse |
Vice President-Investor Relations & Operations Robert Bennett |
Corporate headquarters Durham, North Carolina |
